Details for New Drug Application (NDA): 070050
✉ Email this page to a colleague
NDA 070050 describes VALNAC, which is a drug marketed by Actavis Mid Atlantic and is included in one NDA. It is available from two suppliers. Additional details are available on the VALNAC profile page.
The generic ingredient in VALNAC is betamethasone valerate. There are sixty-six drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
The generic ingredient in VALNAC is betamethasone valerate. There are sixty-six drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
Summary for 070050
| Tradename: | VALNAC |
| Applicant: | Actavis Mid Atlantic |
| Ingredient: | betamethasone valerate |
| Patents: | 0 |
Pharmacology for NDA: 070050
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 070050
Suppliers and Packaging for NDA: 070050
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| VALNAC | betamethasone valerate | CREAM;TOPICAL | 070050 | ANDA | Actavis Pharma, Inc. | 0472-0370 | 0472-0370-15 | 1 TUBE in 1 CARTON (0472-0370-15) / 15 g in 1 TUBE |
| VALNAC | betamethasone valerate | CREAM;TOPICAL | 070050 | ANDA | Actavis Pharma, Inc. | 0472-0370 | 0472-0370-45 | 1 TUBE in 1 CARTON (0472-0370-45) / 45 g in 1 TUBE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CREAM;TOPICAL | Strength | EQ 0.1% BASE | ||||
| Approval Date: | Oct 10, 1984 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
